CT Imaging for Valvular Interventions
- PMID: 40704363
- PMCID: PMC12281215
- DOI: 10.1016/j.shj.2025.100667
CT Imaging for Valvular Interventions
Abstract
Physician-led computed tomography (CT) imaging for valvular interventions has directly contributed to the safety and scalability of transcatheter aortic valve interventions globally. As the shift of the global population's valvular heart disease extends into the transcatheter aortic, mitral, pulmonic, and tricuspid space, CT imaging for valvular interventions in new anatomical pathophysiologies becomes more important than ever. Health systems dedicated to investing in physician-led structural heart imaging CT procedural planning expertise and transcatheter treatment advancements can bring life-saving innovative care to patients in need.
Keywords: 3D; CT; Mitral; TAVR; Transcatheter; Tricuspid.
© 2025 The Authors.
Conflict of interest statement
D.D. Wang is a consultant for Abbott, Edwards Lifesciences, Inari, and Materialise. B.P. O’Neill is a consultant for Edwards Lifesciences, Abbott, Medtronic, Inari, Medicure Pharma, and AngioDynamics. P.A. Villablanca is a consultant for Edwards Lifesciences, Medtronic, Medicure Pharma, and AngioDynamics. K.C. So is a proctor for Abbott Structural Heart, Boston Scientific, Edwards Lifesciences, and Medtronic. R.J.C. received institutional grant support from Edwards Lifesciences. W.W. O’Neill has served as a consultant for Abbott, Abiomed, Boston Scientific, Edwards Lifesciences, and Medtronic. The other author had no conflicts to declare.
Figures
References
-
- Wang D.D., Geske J., Choi A.D., et al. Navigating a career in structural heart disease interventional imaging. JACC Cardiovasc Imaging. 2018;11:1928–1930. - PubMed
-
- Leipsic J., Norgaard B.L., Khalique O., et al. Core Competencies in cardiac CT for imaging structural heart disease interventions: an expert consensus statement. JACC Cardiovasc Imaging. 2019;12:2555–2559. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
